1. Home
  2. LGVN vs ENG Comparison

LGVN vs ENG Comparison

Compare LGVN & ENG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGVN
  • ENG
  • Stock Information
  • Founded
  • LGVN 2014
  • ENG 1985
  • Country
  • LGVN United States
  • ENG United States
  • Employees
  • LGVN N/A
  • ENG N/A
  • Industry
  • LGVN Medicinal Chemicals and Botanical Products
  • ENG Military/Government/Technical
  • Sector
  • LGVN Health Care
  • ENG Consumer Discretionary
  • Exchange
  • LGVN Nasdaq
  • ENG Nasdaq
  • Market Cap
  • LGVN 31.2M
  • ENG 7.2M
  • IPO Year
  • LGVN 2021
  • ENG 1998
  • Fundamental
  • Price
  • LGVN $3.29
  • ENG $1.67
  • Analyst Decision
  • LGVN Strong Buy
  • ENG
  • Analyst Count
  • LGVN 1
  • ENG 0
  • Target Price
  • LGVN $12.00
  • ENG N/A
  • AVG Volume (30 Days)
  • LGVN 11.1M
  • ENG 9.9K
  • Earning Date
  • LGVN 08-09-2024
  • ENG 08-08-2024
  • Dividend Yield
  • LGVN N/A
  • ENG N/A
  • EPS Growth
  • LGVN N/A
  • ENG N/A
  • EPS
  • LGVN N/A
  • ENG N/A
  • Revenue
  • LGVN $978,000.00
  • ENG $32,371,000.00
  • Revenue This Year
  • LGVN $137.24
  • ENG $694.29
  • Revenue Next Year
  • LGVN $50.77
  • ENG N/A
  • P/E Ratio
  • LGVN N/A
  • ENG N/A
  • Revenue Growth
  • LGVN N/A
  • ENG N/A
  • 52 Week Low
  • LGVN $0.77
  • ENG $1.01
  • 52 Week High
  • LGVN $35.60
  • ENG $3.28
  • Technical
  • Relative Strength Index (RSI)
  • LGVN 56.11
  • ENG 58.97
  • Support Level
  • LGVN $3.36
  • ENG $1.34
  • Resistance Level
  • LGVN $4.88
  • ENG $1.82
  • Average True Range (ATR)
  • LGVN 0.69
  • ENG 0.15
  • MACD
  • LGVN 0.06
  • ENG 0.04
  • Stochastic Oscillator
  • LGVN 37.04
  • ENG 70.75

About LGVN Longeveron Inc.

Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.

About ENG ENGlobal Corporation

ENGlobal Corp engages in providing engineering and professional services to the energy industry. The company operates through two segments Commercial and Government Services. The Commercial segment derives revenue on contracts from time-and-material fees charged for professional and technical services. The Government segment provides services related to the design, integration and implementation of process distributed control and analyzer systems, advanced automated data gathering systems, information technology and the maintenance of these systems to the U.S. Government globally.

Share on Social Networks: